Targovax News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Targovax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Targovax Today - Breaking & Trending Today

Targovax ASA - Notice of Annual General Meeting

The Annual General Meeting of Targovax ASA will be held at the Company s offices at Lysaker, on 22 May 2023 at 14:00 CET.

Notice of attendance

Notice of attendance must be received no later than. | April 28, 2023 ....

Renate Birkeli , Erik Digman Wiklund , Andreas Tinglum , Corporate Communications , Annual General Meeting , General Meeting , Digman Wiklund , Targovax Asa Stock Exchange , Press Release , Ater Trvx No0010689326 ,

Targovax ASA: Annual Report 2022 | MarketScreener

On 13 April 2023, the Board of Directors of Targovax ASA approved the Company s Annual Report, including the financial statements for 2022, which will be processed at the Company s annual general. | April 13, 2023 ....

Renate Birkeli , Andreas Tinglum , Erik Digman Wiklund , Company Annual , Corporate Communications , Annual Report , European Single Electronic Format , Financial Report , Oncos Therapeutics , Business Finland , Digman Wiklund , Targovax Asa Stock Exchange , Press Release , Nnual Trvx No0010689326 ,

Targovax ASA: Requested Conversion of Convertible Bonds

Reference is made to Targovax ASA s stock exchange announcement on 9 March 2023, in which the Company announced that it had requested Atlas Special Opportunities, LLC to subscribe and pay for the. | March 30, 2023 ....

Erik Digman Wiklund , Renate Birkeli , Andreas Tinglum , Corporate Communications , Business Enterprises Nw , Atlas Special Opportunities , Special Opportunities , Investment Agreement , Digman Wiklund , Targovax Asa Stock Exchange , Press Release , Or Trvx No0010689326 ,

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

OSLO, Norway, Feb. 28, 2022 /PRNewswire/ Targovax ASA (OSE: TRVX) a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces ....

United States , Lubor Gaal , Prnewswire Targovax , Andreas Tinglum , Erik Digman Wiklund , Renate Birkeli , Bristol Myers Squibb , Corporate Communications Norway , Rd Management Committee At Almirall , University Of California At Berkeley , Chief Financial Officer , Managing Director , Locust Walk , External Innovation , Europe Search , Vectron Therapeutics , Digman Wiklund ,

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

/PRNewswire/ Targovax ASA (OSE: TRVX) a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today. ....

Kristin Willoch Haugen , Prnewswire Targovax , Andreas Tinglum , Erik Digman Wiklund , Renate Birkeli , Corporate Communications Norway , Research Council Of Norway , Innovation Norway , Willoch Haugen , Innovation Norway Oslo Viken , Research Council , Digman Wiklund , Investor Relations ,